Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?
- PMID: 30046719
- PMCID: PMC6055550
- DOI: 10.1002/rth2.12084
Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?
Keywords: anticoagulants; atrial fibrillation; hemorrhage.
References
-
- Healey JS, Eikelboom J, Douketis J, et al. RE‐LY Investigators . Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long‐Term Anticoagulation Therapy (RE‐LY) randomized trial. Circulation. 2012;126:343–8. - PubMed
-
- Spyropoulos AC, Al‐Badri A, Sherwood MW, Douketis JD. Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery. J Thromb Haemost. 2016;14:875–85. - PubMed
-
- Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–962. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources